Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 921-577-3 | CAS number: 1174918-60-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Neurotoxicity
Administrative data
Description of key information
Four studies were identified that examined neurotoxicity endpoints. These studies were comprised of 90-day inhalation toxicity studies (n-pentane; 2-methylbutane; cyclopentane) and a test on nerve conduction velocity and distal latency (n-pentane).
Key value for chemical safety assessment
Additional information
Potential neurotoxic effects of pentanes were evaluated in three select subchronic repeated dose studies via inhalation, each of which contained a neurotoxicity screening component (Takeuchi et al., 1981; Schreiner, 1998; Gamer, 1998). No treatment-related effects related to neurotoxicity were reported in any of these studies. Additionally,nerve conduction velocity and distal latency was measured in rats exposed to n-pentane for 16 weeks via inhalation (Takeuchi et al., 1980). N-pentane did not prolong distal latency or disturb the conduction velocity of the motor nerve and mixed nerve in the rat's tail. No changes were observed in the peripheral nerve, the neuromuscular junction, and muscle fibre of rats exposed to n-pentane at 3000 ppm for 16 weeks. No changes in body weight or behaviour were observed in n-pentane exposed rats when compared with control animals.
Additionally, a relevant and useful supportingstudy also was available for n-pentane (Stoughton, 1936). This information is also presented in the Acute Toxicity section under inhalation. In this study, the anaesthetic activity of n-pentane on mice. In the first test series, referred to as the "light anesthesia" test, two mice were placed in a 2 liter bottle containing the n-pentane gas mixture. During this test, mice were dosed at concentrations of 3.0, 3.5, and 4.2 mmol/L. If animals were unable to maintain their upright posture after spinning the bottle then they were said to be lightly anaesthetized. For the three concentration levels tested, the time it took for mice to become lightly anaesthetized ranged from 1.3 to 10 minutes. No mice died during the first test series. In the second test series, referred to as the "complete anaesthesia" test, five mice were placed in a 20 liter bottle containing the n-pentane gas mixture. During this test, mice were dosed at concentrations of 4.2, 4.5, and 4.9 mmol/L. If animals were unable to regain their upright positioning after shaking then they were said to be anaesthetized. After two hours, the mice were removed from the bottle and the number of mortalities was noted. No mortalities occurred at 4.2 mmol/L, 8 mortalities occurred at 4.5 mmol/L, and 7 mortalities occurred at 4.9 mmol/L. The average recovery time for the survivor test mice ranged from 4 to 8 minutes. The LC50 was not calculated. Based on this study, pentanes are classified and labelled for drowsiness and dizziness under Dangerous Substances Directive 67/548/EEC and CLP EU Regulation 1272/2008.
Justification for classification or non-classification
Based on the information presented in the study on anaesthetic activity of n-pentane, hydrocarbons C5 is classified as R67, Vapours may cause drowsiness and dizziness in accordance with Dangerous Substances Directive 67/584/EEC and as STOT Single Exp. 3 (H336: May cause drowsiness or dizziness) in accordance with CLP EU Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.